Skip to Content

Fidelity Advisor® Biotechnology I FBTIX

Quantitative rating as of
  • NAV / 1-Day Return 27.55  /  0.15 %
  • Total Assets 1.8 Bil
  • Adj. Expense Ratio
  • Expense Ratio 0.730%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Mid Growth
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.00
  • Turnover 43%

Morningstar’s Analysis FBTIX

Will FBTIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.



A lowering of its Process Pillar rating is the primary driver of Fidelity Advisor® Biotechnology I's downgrade to a Morningstar Quantitative Rating of Neutral from Bronze. The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Unlock our full analysis with Morningstar Investor